Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ)
CNY 16.5
(-3.85%)
CNY 16.5
(-3.85%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.69 Billion CNY | 14.28% |
| 2022 | 2.32 Billion CNY | 42.92% |
| 2021 | 1.62 Billion CNY | 66.4% |
| 2020 | 978.15 Million CNY | 5.85% |
| 2019 | 924.06 Million CNY | 15.31% |
| 2018 | 801.37 Million CNY | 49.93% |
| 2017 | 534.51 Million CNY | 42.01% |
| 2016 | 376.4 Million CNY | 29.57% |
| 2015 | 290.49 Million CNY | 9.01% |
| 2014 | 266.48 Million CNY | 10.39% |
| 2013 | 241.41 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 584.04 Million CNY | -26.07% |
| 2024 Q2 | 766.42 Million CNY | 31.23% |
| 2024 Q3 | 779.69 Million CNY | 1.73% |
| 2023 FY | 2.65 Billion CNY | 14.28% |
| 2023 Q2 | 715.84 Million CNY | 42.63% |
| 2023 Q1 | 501.87 Million CNY | -30.97% |
| 2023 Q3 | 675.21 Million CNY | -5.68% |
| 2023 Q4 | 790.03 Million CNY | 17.0% |
| 2022 Q2 | 581.89 Million CNY | 29.58% |
| 2022 Q3 | 568.21 Million CNY | -2.35% |
| 2022 FY | 2.32 Billion CNY | 42.92% |
| 2022 Q4 | 727.04 Million CNY | 27.95% |
| 2022 Q1 | 449.06 Million CNY | -9.84% |
| 2021 Q1 | 278.1 Million CNY | -13.45% |
| 2021 FY | 1.62 Billion CNY | 66.4% |
| 2021 Q4 | 498.06 Million CNY | 25.18% |
| 2021 Q3 | 397.86 Million CNY | -12.29% |
| 2021 Q2 | 453.63 Million CNY | 63.11% |
| 2020 Q3 | 263.53 Million CNY | 13.19% |
| 2020 Q2 | 232.82 Million CNY | 45.09% |
| 2020 FY | 978.15 Million CNY | 5.85% |
| 2020 Q1 | 160.46 Million CNY | -39.35% |
| 2020 Q4 | 321.33 Million CNY | 21.93% |
| 2019 Q2 | 247.7 Million CNY | 38.82% |
| 2019 FY | 924.06 Million CNY | 15.31% |
| 2019 Q1 | 178.43 Million CNY | -25.67% |
| 2019 Q3 | 233.33 Million CNY | -5.8% |
| 2019 Q4 | 264.58 Million CNY | 13.39% |
| 2018 Q1 | 168.62 Million CNY | -8.64% |
| 2018 FY | 801.37 Million CNY | 49.93% |
| 2018 Q4 | 240.04 Million CNY | 19.56% |
| 2018 Q3 | 200.76 Million CNY | 4.59% |
| 2018 Q2 | 191.94 Million CNY | 13.83% |
| 2017 Q4 | 184.57 Million CNY | 36.85% |
| 2017 FY | 534.51 Million CNY | 42.01% |
| 2017 Q3 | 134.87 Million CNY | 7.7% |
| 2017 Q2 | 125.23 Million CNY | 39.42% |
| 2017 Q1 | 89.82 Million CNY | -26.22% |
| 2016 Q4 | 121.74 Million CNY | 30.77% |
| 2016 Q3 | 93.09 Million CNY | 15.25% |
| 2016 Q2 | 80.77 Million CNY | 24.04% |
| 2016 Q1 | 65.12 Million CNY | -17.98% |
| 2016 FY | 376.4 Million CNY | 29.57% |
| 2015 Q1 | 65.84 Million CNY | -5.95% |
| 2015 Q4 | 79.39 Million CNY | 0.0% |
| 2015 FY | 290.49 Million CNY | 9.01% |
| 2015 Q3 | 79.39 Million CNY | 20.57% |
| 2015 Q2 | 65.84 Million CNY | 0.0% |
| 2014 Q3 | 70.01 Million CNY | 10.74% |
| 2014 Q1 | 63.22 Million CNY | 0.0% |
| 2014 FY | 266.48 Million CNY | 10.39% |
| 2014 Q2 | 63.22 Million CNY | 0.0% |
| 2014 Q4 | 70.01 Million CNY | -0.0% |
| 2013 FY | 241.41 Million CNY | 0.0% |